COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,141 Articles (22,693 medRxiv, 8,448 bioRxiv)

Most recent first Previous |  Page 846: Articles 8451-8460  | Next

Vaccine Adverse Event Reporting System (VAERS): Evaluation of 31 Years of Reports and Pandemics' Impact
Almadani, O., Alshammari, T. M.
10.1101/2022.03.23.22272819 — Posted: 2022-03-25
International Travel-Related Control Measures to contain The Covid-19 Pandemic: An update to a Cochrane Rapid Review
Hohlfeld, A., abdullahi, l., Abou-Setta, A. M., Engel, M. E.
10.1101/2022.03.24.22271703 — Posted: 2022-03-25
A Computational Pipeline to Identify Potential Drug Targets and Interacting Chemotypes in SARS-CoV-2
Sandholtz, S. H., Drocco, J. A., Zemla, A. T., Torres, M. W., Silva, M. S., Allen, J. E.
10.1101/2022.03.24.485222 — Posted: 2022-03-25
SARS-CoV-2 harnesses host translational shutoff and autophagy to optimize virus yields: The role of the envelope (E) protein
Waisner, H., Grieshaber, B., Saud, R., Henke, W., Stephens, E. B., Kalamvoki, M.
10.1101/2022.03.24.485734 — Posted: 2022-03-25
Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq
Vazquez, S. E., Mann, S. A., Bodansky, A., Kung, A. F., Quandt, Z., Ferre, E. M. N., Landegren, N., Eriksson, D., Bastard, P., Zhang, S.-Y., Liu, J., Mitchell, A., Mandel-Brehm, C., Miao, B., Sowa, G., Zorn, K., Chan, A. Y., Shimizu, C., Tremoulet, A., Lynch, K., Wilson, M. R., Kämpe, O., Dobbs, K., Delmonte, O. M., Notarangelo, L. D., Burns, J. C., Casanova, J.-L., Lionakis, M. S., Torgerson, T. R., Anderson, M. S., DeRisi, J. L.
10.1101/2022.03.23.485509 — Posted: 2022-03-25
Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic
Issac, D., Cohen, S., Hershcovitch, M., Taraz, M., Kissig, O., Waddington, D., Chin, P., Friedrich, T.
10.1101/2022.03.24.485618 — Posted: 2022-03-24
Neutrophils in severe COVID-19 are characterized by a hyperactive immature state and maintained CXCR2 expression
Rice, C. M., Lewis, P., Ponce-Garcia, F. M., Gibbs, W., Cela, D., Hamilton, F., Arnold, D., Hyams, C., Oliver, E., Barr, R., Goenka, A., Davidson, A., Wooldridge, L., Finn, A., Rivino, L., Amulic, B.
10.1101/2022.03.23.22272828 — Posted: 2022-03-24
Production of anti-spike antibodies in response to COVID vaccine in lymphoma patients
Della Pia, A., Kim, G. Y., Ip, A., Ahn, J., Liu, Y., Koropsak, M., Lukasik, B., Contractor, A., Amin, K., Ayyagari, L., Zhao, C., Gupta, A., Batistick, M., Leslie, L., Goy, A., Feldman, T., Kats, S.
10.1101/2022.03.24.22272883 — Posted: 2022-03-24
The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for Long Covid or Post-COVID syndrome
Sivan, M., Preston, N. J., Parkin, A., Makower, S., Gee, J., Ross, D., Tarrant, R., Davison, J., Halpin, S., O'Connor, R. J., Horton, M.
10.1101/2022.03.24.22272892 — Posted: 2022-03-24
Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel
Gazit, S., Saciuk, Y., Perez, G., Peretz, A., Pitzer, V. E., Patalon, T.
10.1101/2022.03.24.22272835 — Posted: 2022-03-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).